coa tirzepatide $125/mo Compounded (vs $1,069 Mounjaro) Tirzepatide 30 mg — ≥99%

those on multiple daily injections

Patented: see www.takeda.com/en-us/patents Revised: 10/2025 PRINCIPAL DISPLAY PANEL - Kit Carton - 250 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] NDC 0944-4622-01 Single-dose only For Intravenous Administration After Reconstitution Only Lyophilized powder for reconstitution ADYNOVATE and diluent preassembled in BAXJECT III system Rx Only Actual potency Takeda PRINCIPAL DISPLAY PANEL - Barrel Label - 250 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] For Intravenous Administration Only ADYNOVATE and diluent preassembled in BAXJECT III system Directions for use: see package insert Rx Only IU: LOT: EXP: Takeda 6521221 PRINCIPAL DISPLAY PANEL - Blister Label - 250 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] NDC 0944-4622-02 Single-dose only 6521479 For Intravenous Administration Only ADYNOVATE and diluent preassembled in BAXJECT III system Do not open until time of use Do not use if packaging is opened or damaged Discard unused portion

Therefore, the improvement in psoriasis is likely indirect through improved glucose control, although specific anti-inflammatory processes have been identified

Wegovy (semaglutide) injection is a well known drug that IS approved by the U.S Food and Drug Administration (2021) for chronic weight management in adults with obesity or are overweight

Therapeutic equivalency is complex, requiring careful clinical judgment rather than a straightforward milligram-for-milligram conversion

D.HooperD